Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's Colitis

Completed

• Conditions: Inflammatory Bowel Diseases; 10017969

• Registration Number: NL-OMON37225
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-03-26
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

-patients (>18 years) with Ulcerative Colitis or Crohn's Colitis who start on Infliximab therapy

Exclusion Criteria

History of previous Infliximab use

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>IFX level in feces</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>